Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential
The episode opens with Daniel Ek’s Spotify origin story, from music piracy and tense label negotiations to the company’s U.S. launch and early scaling. The conversation then shifts to his move into healthcare and the founding of NECO, with a focus on chronic disease, prevention, and using smartphones, sensors, and AI for predictive care. They dig into NECO’s end-to-end checkups, early results, dermatology use cases, wearables, and the challenge of funding preventive care in the U.S. The back half covers AI’s impact on healthcare and music, open source and compute, Spotify’s podcasting strategy, and lessons from Ek’s early startup years in Sweden.
Key Points
- Daniel Ek described how Spotify was built through years of licensing negotiations, market-by-market expansion, and a willingness to bet on subscription music before it was obvious.
- He argued that healthcare needs to move from reactive treatment to prevention by collecting far richer longitudinal data, which is the core idea behind Neko’s diagnostic model.
- He emphasized that AI and wearables become most powerful when paired with clinicians and repeated measurements over time, turning early detection into real behavior change and better outcomes.
Chapters
| 0:00 | |
| 1:40 | |
| 2:00 | |
| 5:44 | |
| 6:17 | |
| 10:20 | |
| 13:38 | |
| 15:13 | |
| 19:17 | |
| 27:22 | |
| 31:45 | |
| 36:03 | |
| 44:24 | |
| 47:28 | |
| 49:47 |
Transcript
Loading transcript...
- / -





